The compound was approved under the FDA Priority Review designation, which is reserved for medicines that may provide significant improvements in the safety or effectiveness of the treatment for serious conditions," Orion said.
Chemical Name |
Synonyms |
Molecular Formula |
Molecular Weight |
---|
Product Name | Innovator |
---|
Product Name | Market Status |
---|
Product Name | Indication |
---|
Product Name | Therapeutic Segment |
---|
Your product will be updated soon in our database